• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@alsmnd-admin

Profile

Registered: 13 years, 4 months ago


Forums

Topics Started: 0

Replies Created: 0

Forum Role: Keymaster

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Jean

    Jean
    jean

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Zabun Nassar, England

    Zabun Nassar, England

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Ali Var, Turkey

    Ali Var, Turkey

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Paul Launer, USA

    Paul Launer, USA

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Michael Lee, Australia

    Michael Lee, Australia

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • David Solomon, UK

    David Solomon, UK

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Mike Cels, Canada

    Mike Cels, Canada

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Art Eggert, USA

    Art Eggert, USA

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Greg Heydet, USA

    Greg Heydet, USA

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Jon Newsome, USA

    Jon Newsome, USA

  • Denis Blais, Canada

    Denis Blais, Canada

  • Rob Tison, USA

    Rob Tison, USA

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login